Key facts
- It has raised $100K; the latest was Seed Round ($100K) in Jan 2025.
- Clear Heart and Lung Imaging has filed 1 Form D with the SEC, most recently Jan 2025 ($100K sold to 1 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Clear Heart and Lung Imaging
- ·The full record, as it builds
Funding rounds
No funding rounds for Clear Heart and Lung Imaging are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clear Heart and Lung Imaging
Developer of cardiac computed tomography (CT) scanning technology intended for the early detection and prevention of heart disease. The company provides coronary CT angiography (CTA) services to visualize coronary arteries through detailed 3D images of the heart and blood vessels, including plaque screening, calcium scoring, FFR-CT analysis, and lung screening, enabling clinicians to assess plaque buildup, arterial blockages, and other abnormalities associated with cardiac conditions.
- Sector
- Healthcare
- HQ
- Loveland, CO, United States
- Founded
- 2023
- Employees
- 4
- Website
- clearheartandlung.com/
- Ownership
- Privately Held (backing)
Clear Heart and Lung Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clear Heart and Lung Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clear Heart and Lung Imaging in its N-PORT filings yet. We sweep new filings monthly.